TNFSF10 and breast cancer: One team who studied spontaneous tumors in mice lacking the tumor necrosis factor (TNF)-apoptosis-inducing ligand (TRAIL) concluded that TRAIL-R did not protect against mammary cancers or against colon cancers, but did protect against lymphoid malignancies, which affected more than 25% of the deficient mice (54).